A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.
The United States will fall short of its Cancer Moonshot goal of cutting cancer deaths by at least half over the next 25 years unless more action is taken, a new U.S. National Cancer Institute analysis concludes.
An experimental blood test may be able to catch a dozen different types of cancer with a high degree of accuracy — including some that are particularly tricky to detect, a preliminary study suggests.
An experimental vaccine whipped up to specifically target a melanoma patient’s tumor cells significantly reduces the likelihood of the cancer recurring, early clinical trial data show.
